Lyne Gagnon
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Human Lung Tissue Implanted on the Chick Chorioallantoic Membrane as a Novel In Vivo Model of Idiopathic Pulmonary Fibrosis.
Journal: American journal of respiratory cell and molecular biology
Published: May 25, 2022
Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: March 29, 2022
PBI-4050 via GPR40 activation improves adenine-induced kidney injury in mice.
Journal: Clinical science (London, England : 1979)
Published: May 13, 2019
PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
Journal: Cardiovascular research
Published: September 20, 2018
PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Journal: The Journal of pharmacology and experimental therapeutics
Published: April 17, 2018
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis.
Journal: The European respiratory journal
Published: April 06, 2018
Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control.
Journal: JCI insight
Published: February 05, 2018
A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84.
Journal: The American journal of pathology
Published: August 11, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026